Veterinary Cancer Therapeutics Market: By Product (Chemotherapeutic Agent, Vaccine, Others), By Cancer (Mast Cell Tumors, Lymphoma, Insulinomas, Chondrosarcoma, Others), By Species (Bovine, Porcine, Cats, Dogs, Others) and Region  

Veterinary Cancer Therapeutics Market size was valued at USD 278.2 million in 2022 and is expected to grow at a CAGR of 11.6% from 2023 to 2029. The global market provides a detailed overview of the Veterinary Cancer Therapeutics market, and that can be segmented by product, by cancer, and by Species. By product, the Veterinary Cancer Therapeutics market has been segmented into Chemotherapeutic Agents, Vaccines, and Others. The chemotherapy segment is likely to be the largest and fastest-growing segment in terms of product. The rise of this segment is mainly due to the growing number of chemotherapeutic events accepted by surgeons owing to the several advantages. As per the oncology guidelines by AAHA, chemotherapy is a frequently used mode of veterinary oncology treatment in veterinary cancer medication.

Moreover, other chemotherapy approaches for example conventional, targeted chemotherapy such as Tyrosine Kinase Inhibitors and metronomic are accepted by small animal doctors. Based on Cancer, the Veterinary Cancer Therapeutics market is segmented into Mast Cell Tumors, Lymphoma, Insulinomas, Chondrosarcoma, and Others. Among these, the lymphoma cancer segment is expected to have the fastest-growing market during the forecast period 2022-2028. The rise of this segment is mainly due to the growing number of the pet population, particularly canines, being suffered by the disease. As per a PubMed report, an assessed incidence rate of 20-100 cases per 100,000 dogs suffered from this disease. Based on the Species, the Veterinary Cancer Therapeutics market is segmented into Bovine, Porcine, Cats, Dogs, and Others. The dogs segment is expected to have a significant share in 2021. The rise of this segment is mainly because of the increasing prevalence of cancer in the dog population and growing life expectancy. Moreover, the rising incidence of cancer in this populace has further involved scientists in comparative veterinary oncology treatment with many clinical trials on dogs as a biological model.

Veterinary Cancer Therapeutics Market Key Developments:

• In September 2022, CureLab Veterinary launched an equity crowdfunding campaign to transform medicine for dogs, cats, and horses
• In June 2022, Ankyra Therapeutics announced a research partnership with the College of Veterinary Medicine.